Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL630P (RNA, 7SL, cytoplasmic 630, pseudogene) is a non-coding RNA pseudogene found in the human genome[1][10]. It is a truncated, non-functional copy derived from the canonical 7SL RNA gene, which encodes an essential scaffold of the signal recognition particle (SRP)[7][9]. Most 7SL pseudogenes, including RN7SL630P, do not encode functional RNA or protein and are the result of retrotransposition events that inserted copies of the 7SL sequence into new genomic loci without retaining their original activity[9]. There is no evidence that RN7SL630P itself is expressed or has a regulatory or direct biological function, nor is it classified as a therapeutic target[1][10][9]. The related canonical gene (RN7SL1/7SL RNA) is well-studied, but this particular pseudogene does not have disease associations or known drug interactions. NOTES: - The entry is for a pseudogene, which by strict definition is *not* considered a protein, enzyme, receptor, or therapeutic target, and is generally not transcribed or functional[1][10][9]. - Most of the relevant literature describes *7SL RNA pseudogenes* collectively as non-functional, serving no direct, characterized biological or disease-related role, though some other pseudogenes can act in regulatory networks in some contexts[4][6]. No evidence specifically implicates RN7SL630P in such roles. Summary: RN7SL630P is a human pseudogene corresponding to 7SL RNA, with no known functional, biological, or therapeutic relevance, and should not be considered a therapeutic target[1][10][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 630, pseudogene (RN7SL630P).